← Back to Search

Behavioural Intervention

Smartphone App for Overdose Prevention

N/A

Waitlist Available

Led By Rachel E Gicquelais, PhD, MPH

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

Study Summary

This trial will study if an app helps drug users lower their risk of overdose and learn about COVID vaccines. 60 people will be involved for 6 months.

Who is the study for?

This trial is for adults over 18 who have used opioids to get high in the last month and injected drugs at least twice in the past week. They must want to reduce their overdose risk and be willing to visit Vivent Health locations in Milwaukee, Appleton, or Eau Claire.Check my eligibility

What is being tested?

The study tests if a smartphone app called Thrive4Life Connect can help drug users decrease their overdose risk and educate them about COVID-19 vaccines. Participants will use this app for up to six months.See study design

What are the potential side effects?

Since this intervention involves using a smartphone application, there are no direct medical side effects; however, participants may experience stress or anxiety related to technology use or content.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Content completion rate assessed through 12 weeks

Secondary outcome measures

Change in COVID-19 Vaccination Rates from baseline

Change in Number of days in the past month endorsing overdose risk behaviors

Trial Design

1Treatment groups

Experimental Treatment

Group I: iThrive WI InterventionExperimental Treatment1 Intervention

Participants will receive COVID-19 and overdose-related educational and motivational content over the course of 12 weeks through the Thrive4Life Connect, a mobile health application. They will be invited to set goals for lowering overdose and COVID-19 risk.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

iThrive WI Intervention

2022

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,183 Previous Clinical Trials

3,167,911 Total Patients Enrolled

14 Trials studying COVID-19

1,667,145 Patients Enrolled for COVID-19

National Institute on Drug Abuse (NIDA)NIH

2,468 Previous Clinical Trials

2,619,288 Total Patients Enrolled

4 Trials studying COVID-19

1,591 Patients Enrolled for COVID-19

Rachel E Gicquelais, PhD, MPHPrincipal InvestigatorUniversity of Wisconsin, Madison

Media Library

Thrive4Life Connect (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05518461 — N/A

COVID-19 Research Study Groups: iThrive WI Intervention

COVID-19 Clinical Trial 2023: Thrive4Life Connect Highlights & Side Effects. Trial Name: NCT05518461 — N/A

Thrive4Life Connect (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05518461 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scale of participants currently enrolled in this research?

"Affirmative. Clinicaltrials.gov records demonstrate that this examination, which was first published on December 19th 2022, is currently recruiting patients. 60 enrollees are anticipated at a single facility."

Answered by AI

Is recruitment currently underway for this medical experiment?

"Affirmative. The information hosted on clinicaltrials.gov reveals that this medical trial is actively enrolling candidates as of December 21st, 2022; the study was initially posted three days prior to that date on Dec 19th, 2022. They are looking for 60 patients across a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Smartphone Intervention for Overdose and COVID-19

2022. "Smartphone Intervention for Overdose and COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05518461.